BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 4894464)

  • 21. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
    Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the action mechanism of lactulose in hepatic coma--clarification of colon urease activity using C-14 urea in rats].
    Bircher J; Gmünder U; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
    Strahlentherapie Sonderb; 1968; 67():330-6. PubMed ID: 5719130
    [No Abstract]   [Full Text] [Related]  

  • 24. [Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].
    Girard PF; Trillet M; Kopp N
    Rev Neurol (Paris); 1972 Nov; 127(5):560-3. PubMed ID: 4668744
    [No Abstract]   [Full Text] [Related]  

  • 25. Lactulose in the treatment of acute and chronic hepatic encephalopathy.
    Fung WP; Khoo OT
    Singapore Med J; 1971 Jun; 12(3):176-80. PubMed ID: 5094427
    [No Abstract]   [Full Text] [Related]  

  • 26. A controlled trial of colon bypass in chronic hepatic encephalopathy.
    Resnick RH; Ishihara A; Chalmers TC; Schimmel EM
    Gastroenterology; 1968 Jun; 54(6):1057-69. PubMed ID: 5656325
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of chronic portal-systemic encephalopathy with lactulose.
    Bircher J; Müller J; Guggenheim P; Haemmerli UP
    Lancet; 1966 Apr; 1(7443):890-2. PubMed ID: 4159616
    [No Abstract]   [Full Text] [Related]  

  • 28. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
    Bircher J; Haemmerli UP; Williams R
    Gastroenterology; 1970 Apr; 58(4):595-7. PubMed ID: 5438009
    [No Abstract]   [Full Text] [Related]  

  • 29. Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.
    Avery GS; Davies EF; Brogden RN
    Drugs; 1972; 4(1):7-48. PubMed ID: 4564869
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term treatment of portal-systemic encephalopathy with lactulose.
    Ma MH; McLeod JG; Blackburn CR
    Australas Ann Med; 1969 May; 18(2):117-23. PubMed ID: 5793699
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study.
    Rorsman G; Sulg I
    Acta Med Scand; 1970 May; 187(5):337-46. PubMed ID: 5526951
    [No Abstract]   [Full Text] [Related]  

  • 33. The mechanism of action of lactulose in portal-systemic encephalopathy. Non-ionic diffusion of ammonia in the canine colon.
    Bircher J; Haemmerli UP; Trabert E; Largiader F; Mocetti T
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):352-7. PubMed ID: 5564547
    [No Abstract]   [Full Text] [Related]  

  • 34. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ
    Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
    Eisenburg J; Krumpoch B; Grunst J; Weinzierl M; Munte A; Schmidt S; Magerl W; Schauer S
    Fortschr Med; 1972 Aug; 90(24):837-48. PubMed ID: 4639347
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lactulose treatment in three patients with chronic portal-systemic encephalopathy].
    Tamai Y; Iwata Y; Tsuji M; Minakuchi C; Nagakawa J
    Naika Hokan; 1972 Apr; 19(4):113-8. PubMed ID: 5065961
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
    Sala Felis T; Berenguer J; Barrios JM; Gómez J
    Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatic encephalopathy and liver transplantation].
    Fehérvári I; Nemes B; Görög D; Gerlei Z; Kóbori L
    Magy Seb; 2012 Apr; 65(2):58-62. PubMed ID: 22512880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 40. [The blood ammonia electroencephalogram pattern in the evaluation of portosystemic encephalopathy].
    Bataller Sifre R; López Gómez LJ; Abella Llácer A; Berto Navarro R; González Marrtínez M
    Rev Esp Enferm Apar Dig; 1972 Feb; 36(3):293-304. PubMed ID: 5058815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.